Martingale Asset Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
Martingale Asset Management's VCYT Position: Q3 2025 in Review
Martingale Asset Management sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 10,853 shares — an estimated $293K sold.
Martingale Asset Management first reported a position in VCYT in Q4 2022 and held it in 11 quarters. The position peaked at $953K in Q4 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.
- Martingale Asset Management reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
- Martingale Asset Management sold 10,853 Veracyte shares in Q3 2025, an estimated $293K.
- Martingale Asset Management first reported a position in Veracyte in Q4 2022 and held it in 11 quarters.
- Martingale Asset Management's Veracyte position peaked at $953K in Q4 2024.
- 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.
Based on Martingale Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.